Principal Financial Group Inc Edwards Lifesciences Corp Transaction History

Principal Financial Group Inc

  • $1.66 Trillion
  • Q3 2024

A detailed history of Principal Financial Group Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 817,516 shares of EW stock, worth $61.2 Million. This represents 3.26% of its overall portfolio holdings.

Number of Shares
817,516
Holding current value
$61.2 Million
% of portfolio
3.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 19, 2024
BUY
$59.7 - $93.78 $48.8 Million - $76.7 Million
817,516 New
817,516 $53.9 Billion
Q2 2024

Jul 29, 2024
SELL
$84.3 - $94.31 $717,140 - $802,295
-8,507 Reduced 1.05%
799,869 $73.9 Million
Q1 2024

Apr 29, 2024
SELL
$72.54 - $95.56 $831,380 - $1.1 Million
-11,461 Reduced 1.4%
808,376 $77.2 Million
Q4 2023

Feb 07, 2024
SELL
$61.71 - $77.76 $784,457 - $988,485
-12,712 Reduced 1.53%
819,837 $62.5 Million
Q3 2023

Nov 02, 2023
SELL
$69.28 - $93.38 $9.98 Million - $13.4 Million
-144,021 Reduced 14.75%
832,549 $57.7 Million
Q2 2023

Aug 07, 2023
BUY
$81.41 - $94.33 $3.09 Million - $3.58 Million
37,963 Added 4.04%
976,570 $92.1 Million
Q1 2023

May 09, 2023
SELL
$74.26 - $84.51 $2.77 Million - $3.15 Million
-37,292 Reduced 3.82%
938,607 $77.7 Million
Q4 2022

Feb 09, 2023
SELL
$68.3 - $87.44 $4.76 Million - $6.1 Million
-69,725 Reduced 6.67%
975,899 $72.8 Million
Q3 2022

Nov 09, 2022
BUY
$82.37 - $107.29 $777,737 - $1.01 Million
9,442 Added 0.91%
1,045,624 $86.4 Million
Q2 2022

Aug 10, 2022
BUY
$86.5 - $128.27 $4.2 Million - $6.23 Million
48,594 Added 4.92%
1,036,182 $98.5 Million
Q1 2022

May 09, 2022
BUY
$101.96 - $128.34 $4.61 Million - $5.8 Million
45,181 Added 4.79%
987,588 $116 Million
Q4 2021

Feb 09, 2022
SELL
$106.37 - $130.68 $3.01 Million - $3.7 Million
-28,341 Reduced 2.92%
942,407 $122 Million
Q3 2021

Nov 09, 2021
BUY
$102.91 - $122.75 $3.18 Million - $3.79 Million
30,864 Added 3.28%
970,748 $110 Million
Q2 2021

Aug 10, 2021
SELL
$83.84 - $104.76 $478,307 - $597,655
-5,705 Reduced 0.6%
939,884 $97.3 Million
Q1 2021

May 10, 2021
SELL
$78.68 - $90.67 $5.8 Million - $6.69 Million
-73,748 Reduced 7.23%
945,589 $79.1 Million
Q4 2020

Feb 08, 2021
SELL
$71.69 - $91.23 $6.94 Million - $8.84 Million
-96,855 Reduced 8.68%
1,019,337 $93 Million
Q3 2020

Nov 06, 2020
SELL
$67.19 - $87.44 $2.97 Million - $3.87 Million
-44,267 Reduced 3.81%
1,116,192 $89.1 Million
Q2 2020

Aug 05, 2020
BUY
$57.54 - $76.95 $46.2 Million - $61.8 Million
803,162 Added 224.79%
1,160,459 $80.2 Million
Q1 2020

May 12, 2020
SELL
$52.41 - $81.0 $787,879 - $1.22 Million
-15,033 Reduced 4.04%
357,297 $67.4 Million
Q4 2019

Feb 05, 2020
SELL
$71.7 - $82.09 $286,298 - $327,785
-3,993 Reduced 1.06%
372,330 $86.9 Million
Q3 2019

Nov 13, 2019
BUY
$61.55 - $75.43 $7,016 - $8,599
114 Added 0.03%
376,323 $82.8 Million
Q2 2019

Aug 12, 2019
SELL
$55.74 - $64.41 $2.57 Million - $2.97 Million
-46,076 Reduced 10.91%
376,209 $69.5 Million
Q1 2019

May 10, 2019
SELL
$47.89 - $64.05 $1.73 Million - $2.31 Million
-36,127 Reduced 7.88%
422,285 $80.8 Million
Q4 2018

Feb 14, 2019
BUY
$46.41 - $56.94 $418,478 - $513,427
9,017 Added 2.01%
458,412 $70.2 Million
Q3 2018

Nov 14, 2018
BUY
$45.7 - $58.03 $319,351 - $405,513
6,988 Added 1.58%
449,395 $78.2 Million
Q2 2018

Aug 13, 2018
SELL
$42.45 - $51.3 $817,035 - $987,371
-19,247 Reduced 4.17%
442,407 $0
Q1 2018

May 14, 2018
BUY
$37.19 - $47.45 $879,617 - $1.12 Million
23,652 Added 5.4%
461,654 $64.4 Million
Q4 2017

Feb 13, 2018
SELL
$33.79 - $39.39 $913,174 - $1.06 Million
-27,025 Reduced 5.81%
438,002 $49.4 Million
Q3 2017

Nov 02, 2017
BUY
$36.29 - $38.83 $16.9 Million - $18.1 Million
465,027
465,027 $50.8 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
457M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email